BMRA Stock Price History and Quote Analysis: Insights for Investors
Biomerica, Inc.
Stock Price Today
Biomerica, Inc. (BMRA) stock surged +3.06%, trading at $0.34 on NASDAQ, up from the previous close of $0.33. The stock opened at $0.33, fluctuating between $0.33 and $0.36 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Company Information
| Employees | 64 |
| Beta | -1.11 |
| Sales or Revenue | $5.42M |
| 5Y Sales Change% | -0.419% |
| Fiscal Year Ends | May |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
Biomerica, Inc. (NASDAQ: BMRA) stock price is $0.34 in the last trading session. During the trading session, BMRA stock reached the peak price of $0.36 while $0.33 was the lowest point it dropped to. The percentage change in BMRA stock occurred in the recent session was 3.06% while the dollar amount for the price change in BMRA stock was $0.01.
The NASDAQ listed BMRA is part of Medical - Devices industry that operates in the broader Healthcare sector. Biomerica, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Robert W. Carlson
Chief Commercial Officer
Mr. Allen C. Barbieri
Executive Vice-Chairman & Corporation Sec.
Hans Boehringer
Senior Vice President of POC R&D
Mr. Zackary S. Irani
Chairman & Chief Executive Officer
Mr. Steven Sloan
Interim Chief Financial Officer & Treasurer
Ms. Lucy Liu Ph.D.
Director of Manufacturing & Technical Operations
Mr. Gary Lu CPA
Principal Accounting Officer & Chief Financial Officer
Mr. Gary Lu
Chief Financial Officer
BMRA's closing price is 37.5% higher than its 52-week low of $0.24 where as its distance from 52-week high of $2.13 is -84.51%.
Number of BMRA employees currently stands at 64.
Official Website of BMRA is: https://www.biomerica.com
BMRA could be contacted at phone 949 645 2111 and can also be accessed through its website. BMRA operates from 17571 Von Karman Avenue, Irvine, CA 92614, United States.
BMRA stock volume for the day was 21.76K shares. The average number of BMRA shares traded daily for last 3 months was 361.25K.
The market value of BMRA currently stands at $5.72M with its latest stock price at $0.34 and 16.82M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com